Latest News

Recent Publications

Mind the Itch.Matuskey D. JAMA Neurol. 2025 Apr 7; 2025 Apr 7. PMID: 40193091.
(11)C-UCB-J PET imaging is consistent with lower synaptic density in autistic adults.Matuskey D, Yang Y, Naganawa M, Koohsari S, Toyonaga T, Gravel P, Pittman B, Torres K, Pisani L, Finn C, Cramer-Benjamin S, Herman N, Rosenthal LH, Franke CJ, Walicki BM, Esterlis I, Skosnik P, Radhakrishnan R, Wolf JM, Nabulsi N, Ropchan J, Huang Y, Carson RE, Naples AJ, McPartland JC. Mol Psychiatry. 2025 Apr; 2024 Oct 4. PMID: 39367053.
Generating synthetic brain PET images of synaptic density based on MR T1 images using deep learning.Zheng X, Worhunsky P, Liu Q, Guo X, Chen X, Sun H, Zhang J, Toyonaga T, Mecca AP, O'Dell RS, van Dyck CH, Angarita GA, Cosgrove K, D'Souza D, Matuskey D, Esterlis I, Carson RE, Radhakrishnan R, Liu C. EJNMMI Phys. 2025 Mar 31; 2025 Mar 31. PMID: 40163154.
Network-based Molecular Constraints on in vivo Synaptic Density Alterations in Schizophrenia.Chopra S, Worhunsky PD, Naganawa M, Zhang XH, Segal A, Orchard E, Cropley V, Wood S, Angarita GA, Cosgrove K, Matuskey D, Nabulsi NB, Huang Y, Carson RE, Esterlis I, Skosnik PD, D'Souza DC, Holmes AJ, Radhakrishnan R. medRxiv. 2025 Mar 23; 2025 Mar 23. PMID: 40166544.
An In Vivo Examination of the Relationship Between Metabotropic Glutamate 5 Receptor and Suicide Attempts in People With Borderline Personality Disorder.Davis MT, Asch RH, Weiss ER, Wagner A, Fineberg SK, Nabulsi N, Matuskey D, Carson RE, Esterlis I. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Mar; 2024 Nov 28. PMID: 39613160.
Socioenvironmental Factors are Associated With Dopamine Transporter Availability in Healthy Individuals but not in Parkinson's Disease.Cayir S, Tezel M, Matuskey D. J Geriatr Psychiatry Neurol. 2025 Mar; 2024 Sep 7. PMID: 39244698.
Quantitative Accuracy Assessment of the NeuroEXPLORER for Diverse Imaging Applications: Moving Beyond Standard Evaluations.Omidvari N, Shanina E, Leung EK, Sun X, Li Y, Mulnix T, Gravel P, Henry S, Matuskey D, Volpi T, Jones T, Badawi RD, Li H, Carson RE, Qi J, Cherry SR. J Nucl Med. 2025 Jan 3; 2025 Jan 3. PMID: 39638433.
Noninvasive quantification of [(18)F]SynVesT-1 binding using simplified reference tissue model 2.Naganawa M, Gallezot JD, Li S, Nabulsi NB, Henry S, Cai Z, Matuskey D, Huang Y, Carson RE. Eur J Nucl Med Mol Imaging. 2024 Dec; 2024 Aug 19. PMID: 39155309.
Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [(18)F]FE-PE2I PET: independent validation with new insights.Honhar P, Ebrahimian Sadabad F, Tinaz S, Gallezot JD, Dias M, Naganawa M, Yang Y, Henry S, Hillmer AT, Gao H, Najafzadeh S, Comley R, Nabulsi N, Huang Y, Finnema SJ, Carson RE, Matuskey D. Brain Commun. 2024; 2024 Oct 2. PMID: 39429243.
Relationship between neuroimaging and cognition in frontotemporal dementia: An FDG-PET and structural MRI study.Cayir S, Volpi T, Toyonaga T, Gallezot JD, Yang Y, Sadabad FE, Mulnix T, Mecca AP, Fesharaki-Zadeh A, Matuskey D. J Neuroimaging. 2024 Sep-Oct; 2024 Apr 26. PMID: 38676301.
Performance Characteristics of the NeuroEXPLORER, a Next-Generation Human Brain PET/CT Imager.Li H, Badawi RD, Cherry SR, Fontaine K, He L, Henry S, Hillmer AT, Hu L, Khattar N, Leung EK, Li T, Li Y, Liu C, Liu P, Lu Z, Majewski S, Matuskey D, Morris ED, Mulnix T, Omidvari N, Samanta S, Selfridge A, Sun X, Toyonaga T, Volpi T, Zeng T, Jones T, Qi J, Carson RE. J Nucl Med. 2024 Aug 1; 2024 Aug 1. PMID: 38871391.
A review of the kappa opioid receptor system in opioid use.Cayir S, Zhornitsky S, Barzegary A, Sotomayor-Carreño E, Sarfo-Ansah W, Funaro MC, Matuskey D, Angarita G. Neurosci Biobehav Rev. 2024 Jul; 2024 May 10. PMID: 38733895.
Decreased Synaptic Vesicle Glycoprotein 2A Binding in the Human Postmortem Essential Tremor Cerebellum: Evidence of Reduction in Synaptic Density.Yang Y, Zheng C, Chen B, Hernandez NC, Faust PL, Cai Z, Louis ED, Matuskey D. Cerebellum. 2024 Jun; 2023 Oct 3. PMID: 37783917.
Does seasonal variation affect the neuroimmune system? A retrospective [(11)C]PBR28 PET study in healthy individuals.Ibrahim W, An J, Yang Y, Cosgrove KP, Matuskey D. Neurosci Lett. 2024 Apr 1; 2024 Apr 5. PMID: 38583505.
Author Correction: Synaptic loss and its association with symptom severity in Parkinson's disease.Holmes SE, Honhar P, Tinaz S, Naganawa M, Hilmer AT, Gallezot JD, Dias M, Yang Y, Toyonaga T, Esterlis I, Mecca A, Van Dyck C, Henry S, Ropchan J, Nabulsi N, Louis ED, Comley R, Finnema SJ, Carson RE, Matuskey D. NPJ Parkinsons Dis. 2024 Mar 12; 2024 Mar 12. PMID: 38472206.
Imaging a putative marker of brain cortisol regulation in alcohol use disorder.Verplaetse TL, Hillmer AT, Bhatt S, Rusowicz A, Li S, Nabulsi N, Matuskey D, Huang Y, McKee SA, Cosgrove KP. Neurobiol Stress. 2024 Mar; 2024 Jan 21. PMID: 38304303.
The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [(11)C]UCB-J.Toyonaga T, Khattar N, Wu Y, Lu Y, Naganawa M, Gallezot JD, Matuskey D, Mecca AP, Pittman B, Dias M, Nabulsi NB, Finnema SJ, Chen MK, Arnsten A, Radhakrishnan R, Skosnik PD, D'Souza DC, Esterlis I, Huang Y, van Dyck CH, Carson RE. Eur J Nucl Med Mol Imaging. 2024 Mar; 2023 Nov 13. PMID: 37955791.
Synaptic loss and its association with symptom severity in Parkinson's disease.Holmes SE, Honhar P, Tinaz S, Naganawa M, Hilmer AT, Gallezot JD, Dias M, Yang Y, Toyonaga T, Esterlis I, Mecca A, Van Dyck C, Henry S, Ropchan J, Nabulsi N, Louis ED, Comley R, Finnema SJ, Carson RE, Matuskey D. NPJ Parkinsons Dis. 2024 Feb 24; 2024 Feb 24. PMID: 38402233.
First-in-Human Study of (18)F-SynVesT-2: An SV2A PET Imaging Probe with Fast Brain Kinetics and High Specific Binding.Drake LR, Wu Y, Naganawa M, Asch R, Zheng C, Najafzadeh S, Pracitto R, Lindemann M, Li S, Ropchan J, Labaree D, Emery PR, Dias M, Henry S, Nabulsi N, Matuskey D, Hillmer AT, Gallezot JD, Carson RE, Cai Z, Huang Y. J Nucl Med. 2024 Feb 15; 2024 Feb 15. PMID: 38360052.
The Relationship of Cerebrospinal Fluid Biomarkers and Cognitive Performance in Frontotemporal Dementia.Cayir S, Sadabad FE, Mecca A, Matuskey D, Zadeh AF. Res Sq. 2024 Feb 13; 2024 Feb 13. PMID: 38410483.
Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson's disease.de Laat B, Hoye J, Stanley G, Hespeler M, Ligi J, Mohan V, Wooten DW, Zhang X, Nguyen TD, Key J, Colonna G, Huang Y, Nabulsi N, Patel A, Matuskey D, Morris ED, Tinaz S. NPJ Parkinsons Dis. 2024 Feb 9; 2024 Feb 9. PMID: 38336768.
Improving SUVR quantification by correcting for radiotracer clearance in tissue.Honhar P, Matuskey D, Carson RE, Hillmer AT. J Cereb Blood Flow Metab. 2024 Feb; 2023 Aug 17. PMID: 37589538.
Relationship between Neuroimaging and Cognition in Frontotemporal Dementia: A [18 F]FDG PET and Structural MRI Study.Cayir S, Volpi T, Toyonaga T, Gallezot JD, Yanghong Y, Sadabad FE, Mulnix T, Mecca AP, Fesharaki-Zadeh A, Matuskey D. Res Sq. 2024 Jan 15; 2024 Jan 15. PMID: 38313264.
Relationships of in vivo brain norepinephrine transporter and age, BMI, and gender.Koohsari S, Sadabad FE, Pittman B, Gallezot JD, Carson RE, van Dyck CH, Li CR, Potenza MN, Matuskey D. Synapse. 2023 Sep; 2023 Jun 29. PMID: 37382240.
Imaging the brain's immune response to alcohol with [(11)C]PBR28 TSPO Positron Emission Tomography.Raval NR, Angarita G, Matuskey D, Miller R, Drake LR, Kapinos M, Nabulsi N, Huang Y, Carson RE, O'Malley SS, Cosgrove KP, Hillmer AT. Mol Psychiatry. 2023 Aug; 2023 Aug 2. PMID: 37532797.
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression.Jauhar S, Arnone D, Baldwin DS, Bloomfield M, Browning M, Cleare AJ, Corlett P, Deakin JFW, Erritzoe D, Fu C, Fusar-Poli P, Goodwin GM, Hayes J, Howard R, Howes OD, Juruena MF, Lam RW, Lawrie SM, McAllister-Williams H, Marwaha S, Matuskey D, McCutcheon RA, Nutt DJ, Pariante C, Pillinger T, Radhakrishnan R, Rucker J, Selvaraj S, Stokes P, Upthegrove R, Yalin N, Yatham L, Young AH, Zahn R, Cowen PJ. Mol Psychiatry. 2023 Aug; 2023 Jun 16. PMID: 37322065.
Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.Holmes SE, Asch RH, Davis MT, DellaGioia N, Pashankar N, Gallezot JD, Nabulsi N, Matuskey D, Sanacora G, Carson RE, Blumberg HP, Esterlis I. Biol Psychiatry. 2023 Jun 15; 2022 Nov 8. PMID: 36764853.
Decreased Synaptic Vesicle Glycoprotein 2A Binding in the Human Postmortem Essential Tremor Cerebellum: Evidence of Reduction in Synaptic Density.Yang Y, Zheng C, Chen B, Hernandez NC, Faust PL, Cai Z, Louis ED, Matuskey D. Res Sq. 2023 May 2; 2023 May 2. PMID: 37205584.
Cholinergic system adaptations are associated with cognitive function in people recently abstinent from smoking: a (-)-[(18)F]flubatine PET study.Calakos KC, Hillmer AT, Anderson JM, LeVasseur B, Baldassarri SR, Angarita GA, Matuskey D, Kapinos M, Zheng MQ, Huang Y, Cosgrove KP. Neuropsychopharmacology. 2023 Mar; 2023 Jan 21. PMID: 36681758.
Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults.Matuskey D, Gallezot JD, Nabulsi N, Henry S, Torres K, Dias M, Angarita GA, Huang Y, Shoaf SE, Carson RE, Mehrotra S. J Psychopharmacol. 2023 Feb; 2022 Dec 14. PMID: 36515395.
D3 Receptors and PET Imaging.Koohsari S, Yang Y, Matuskey D. Curr Top Behav Neurosci. 2023. PMID: 35711027.
Age, gender and body-mass-index relationships with in vivo CB(1) receptor availability in healthy humans measured with [(11)C]OMAR PET.Radhakrishnan R, Worhunsky PD, Zheng MQ, Najafzadeh S, Gallezot JD, Planeta B, Henry S, Nabulsi N, Ranganathan M, Skosnik PD, Pittman B, Cyril D'Souza D, Carson RE, Huang Y, Potenza MN, Matuskey D. Neuroimage. 2022 Dec 1; 2022 Oct 13. PMID: 36243269.
Systemic inflammation enhances stimulant-induced striatal dopamine elevation in tobacco smokers.Zakiniaeiz Y, Hoye J, Ryan Petrulli J, LeVasseur B, Stanley G, Gao H, Najafzadeh S, Ropchan J, Nabulsi N, Huang Y, Chen MK, Matuskey D, Barron DS, Kelmendi B, Fulbright RK, Hampson M, Cosgrove KP, Morris ED. Brain Behav Immun. 2022 Nov; 2022 Sep 1. PMID: 36058419.
Nicotine Patch Alters Patterns of Cigarette Smoking-Induced Dopamine Release: Patterns Relate to Biomarkers Associated With Treatment Response.Zakiniaeiz Y, Liu H, Gao H, Najafzadeh S, Ropchan J, Nabulsi N, Huang Y, Matuskey D, Chen MK, Cosgrove KP, Morris ED. Nicotine Tob Res. 2022 Oct 17. PMID: 35100429.
Imaging of Synaptic Density in Neurodegenerative Disorders.Carson RE, Naganawa M, Toyonaga T, Koohsari S, Yang Y, Chen MK, Matuskey D, Finnema SJ. J Nucl Med. 2022 Jun. PMID: 35649655.
Imaging the effect of ketamine on synaptic density (SV2A) in the living brain.Holmes SE, Finnema SJ, Naganawa M, DellaGioia N, Holden D, Fowles K, Davis M, Ropchan J, Emory P, Ye Y, Nabulsi N, Matuskey D, Angarita GA, Pietrzak RH, Duman RS, Sanacora G, Krystal JH, Carson RE, Esterlis I. Mol Psychiatry. 2022 Apr; 2022 Feb 15. PMID: 35165397.
Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer (11)C-TASP699.Naganawa M, Nabulsi NB, Matuskey D, Henry S, Ropchan J, Lin SF, Gao H, Pracitto R, Labaree D, Zhang MR, Suhara T, Nishino I, Sabia H, Ozaki S, Huang Y, Carson RE. J Nucl Med. 2022 Apr; 2021 Aug 12. PMID: 34385336.
Recently Abstinent Smokers Exhibit Mood-Associated Dopamine Dysfunction in the Ventral Striatum Compared to Nonsmokers: A [11C]-(+)-PHNO PET Study.Calakos KC, Hillmer AT, Angarita GA, Baldassarri SR, Najafzadeh S, Emery PR, Matuskey D, Huang Y, Cosgrove KP. Nicotine Tob Res. 2022 Mar 26. PMID: 34628508.
Relationships between dopamine D2/3 receptor availability and social-environmental factors in humans.Calakos KC, Rusowicz A, Pittman B, Gallezot JD, Potenza MN, Cosgrove KP, Matuskey D. Neurosci Lett. 2022 Feb 6; 2022 Jan 17. PMID: 35051435.
Looking Back at the Next 40 Years of ASD Neuroscience Research.McPartland JC, Lerner MD, Bhat A, Clarkson T, Jack A, Koohsari S, Matuskey D, McQuaid GA, Su WC, Trevisan DA. J Autism Dev Disord. 2021 Dec; 2021 May 27. PMID: 34043128.
Imaging brain cortisol regulation in PTSD with a target for 11β-hydroxysteroid dehydrogenase type 1.Bhatt S, Hillmer AT, Rusowicz A, Nabulsi N, Matuskey D, Angarita GA, Najafzadeh S, Kapinos M, Southwick SM, Krystal JH, Carson RE, Huang Y, Cosgrove KP. J Clin Invest. 2021 Oct 15. PMID: 34651587.
Assessment of transient dopamine responses to smoked cannabis.Calakos KC, Liu H, Lu Y, Anderson JM, Matuskey D, Nabulsi N, Ye Y, Skosnik PD, D'Souza DC, Morris ED, Cosgrove KP, Hillmer AT. Drug Alcohol Depend. 2021 Oct 1; 2021 Jul 29. PMID: 34399137.
Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [(18)F]FPEB PET.Mecca AP, Rogers K, Jacobs Z, McDonald JW, Michalak HR, DellaGioia N, Zhao W, Hillmer AT, Nabulsi N, Lim K, Ropchan J, Huang Y, Matuskey D, Esterlis I, Carson RE, van Dyck CH. Neuroimage. 2021 Sep; 2021 May 27. PMID: 34052464.
Identifying brain networks in synaptic density PET ((11)C-UCB-J) with independent component analysis.Fang XT, Toyonaga T, Hillmer AT, Matuskey D, Holmes SE, Radhakrishnan R, Mecca AP, van Dyck CH, D'Souza DC, Esterlis I, Worhunsky PD, Carson RE. Neuroimage. 2021 Aug 15; 2021 May 15. PMID: 34000404.
Psychiatric Hospitalizations Before and After Firearm Reform in Connecticut.Matuskey D, Pittman B. Psychiatr Serv. 2021 May 1. PMID: 33950745.
Assessment of test-retest reproducibility of [(18)F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A.Li S, Naganawa M, Pracitto R, Najafzadeh S, Holden D, Henry S, Matuskey D, Emery PR, Cai Z, Ropchan J, Nabulsi N, Carson RE, Huang Y. Eur J Nucl Med Mol Imaging. 2021 May; 2021 Jan 8. PMID: 33416954.
Binding of the synaptic vesicle radiotracer [(11)C]UCB-J is unchanged during functional brain activation using a visual stimulation task.Smart K, Liu H, Matuskey D, Chen MK, Torres K, Nabulsi N, Labaree D, Ropchan J, Hillmer AT, Huang Y, Carson RE. J Cereb Blood Flow Metab. 2021 May; 2020 Aug 5. PMID: 32757741.
Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder.Angarita GA, Matuskey D, Pittman B, Costeines JL, Potenza MN, Jastreboff AM, Schmidt HD, Malison RT. Drug Alcohol Depend. 2021 Apr 1; 2021 Feb 15. PMID: 33621809.
First-in-Human Assessment of (11)C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer.Naganawa M, Nabulsi N, Henry S, Matuskey D, Lin SF, Slieker L, Schwarz AJ, Kant N, Jesudason C, Ruley K, Navarro A, Gao H, Ropchan J, Labaree D, Carson RE, Huang Y. J Nucl Med. 2021 Apr; 2020 Aug 28. PMID: 32859711.
First-in-Human Evaluation of (18)F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.Naganawa M, Li S, Nabulsi N, Henry S, Zheng MQ, Pracitto R, Cai Z, Gao H, Kapinos M, Labaree D, Matuskey D, Huang Y, Carson RE. J Nucl Med. 2021 Apr; 2020 Aug 28. PMID: 32859701.
Dopamine D(2/3) receptor availability in cocaine use disorder individuals with obesity as measured by [(11)C]PHNO PET.Matuskey D, Angarita GA, Worhunsky P, Koohsari S, Gravel P, Pittman B, Gaiser EC, Gallezot JD, Nabulsi N, Huang Y, Carson RE, Potenza MN, Malison RT. Drug Alcohol Depend. 2021 Mar 1; 2021 Jan 8. PMID: 33454626.
Simplified Quantification of (11)C-UCB-J PET Evaluated in a Large Human Cohort.Naganawa M, Gallezot JD, Finnema SJ, Matuskey D, Mecca A, Nabulsi NB, Labaree D, Ropchan J, Malison RT, D'Souza DC, Esterlis I, Detyniecki K, van Dyck CH, Huang Y, Carson RE. J Nucl Med. 2021 Mar; 2020 Jul 9. PMID: 32646875.
Multimodal investigation of dopamine D(2)/D(3) receptors, default mode network suppression, and cognitive control in cocaine-use disorder.Worhunsky PD, Angarita GA, Zhai ZW, Matuskey D, Gallezot JD, Malison RT, Carson RE, Potenza MN. Neuropsychopharmacology. 2021 Jan; 2020 Oct 2. PMID: 33007778.
Kinetic Modeling and Test-Retest Reproducibility of (11)C-EKAP and (11)C-FEKAP, Novel Agonist Radiotracers for PET Imaging of the κ-Opioid Receptor in Humans.Naganawa M, Li S, Nabulsi N, Lin SF, Labaree D, Ropchan J, Gao H, Mei M, Henry S, Matuskey D, Carson RE, Huang Y. J Nucl Med. 2020 Nov; 2020 Mar 13. PMID: 32169917.
Measuring the effects of ketamine on mGluR5 using [(18)F]FPEB and PET.Holmes SE, Gallezot JD, Davis MT, DellaGioia N, Matuskey D, Nabulsi N, Krystal JH, Javitch JA, DeLorenzo C, Carson RE, Esterlis I. J Cereb Blood Flow Metab. 2020 Nov; 2019 Nov 19. PMID: 31744389.
Body Mass Index and Age Effects on Brain 11β-Hydroxysteroid Dehydrogenase Type 1: a Positron Emission Tomography Study.Bini J, Bhatt S, Hillmer AT, Gallezot JD, Nabulsi N, Pracitto R, Labaree D, Kapinos M, Ropchan J, Matuskey D, Sherwin RS, Jastreboff AM, Carson RE, Cosgrove K, Huang Y. Mol Imaging Biol. 2020 Aug. PMID: 32133575.
Tobacco Smoking in People Is Not Associated with Altered 18-kDa Translocator Protein Levels: A PET Study.Hillmer AT, Matuskey D, Huang Y, Nabulsi N, Ropchan J, Carson RE, O'Malley SS, Cosgrove KP. J Nucl Med. 2020 Aug; 2020 Jan 31. PMID: 32005773.
Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand (11)C-UCB-J.Bini J, Holden D, Fontaine K, Mulnix T, Lu Y, Matuskey D, Ropchan J, Nabulsi N, Huang Y, Carson RE. EJNMMI Res. 2020 Jul 14; 2020 Jul 14. PMID: 32666239.
PTSD is associated with neuroimmune suppression: evidence from PET imaging and postmortem transcriptomic studies.Bhatt S, Hillmer AT, Girgenti MJ, Rusowicz A, Kapinos M, Nabulsi N, Huang Y, Matuskey D, Angarita GA, Esterlis I, Davis MT, Southwick SM, Friedman MJ, Duman RS, Carson RE, Krystal JH, Pietrzak RH, Cosgrove KP. Nat Commun. 2020 May 12; 2020 May 12. PMID: 32398677.
PET Imaging of Pancreatic Dopamine D(2) and D(3) Receptor Density with (11)C-(+)-PHNO in Type 1 Diabetes.Bini J, Sanchez-Rangel E, Gallezot JD, Naganawa M, Nabulsi N, Lim K, Najafzadeh S, Shirali A, Ropchan J, Matuskey D, Huang Y, Herold KC, Harris PE, Sherwin RS, Carson RE, Cline GW. J Nucl Med. 2020 Apr; 2019 Oct 10. PMID: 31601695.
First in-human PET study and kinetic evaluation of [(18)F]AS2471907 for imaging 11β-hydroxysteroid dehydrogenase type 1.Bhatt S, Nabulsi NB, Li S, Cai Z, Matuskey D, Bini J, Najafzadeh S, Kapinos M, Ropchan JR, Carson RE, Cosgrove KP, Huang Y, Hillmer AT. J Cereb Blood Flow Metab. 2020 Apr; 2019 Mar 21. PMID: 30895878.
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging.Matuskey D, Tinaz S, Wilcox KC, Naganawa M, Toyonaga T, Dias M, Henry S, Pittman B, Ropchan J, Nabulsi N, Suridjan I, Comley RA, Huang Y, Finnema SJ, Carson RE. Ann Neurol. 2020 Mar; 2020 Feb 5. PMID: 31953875.
Further in vivo characterization of [(11) C]-(+)-PHNO uptake into a retina-like region of interest in humans.Caravaggio F, Worhunsky P, Graff-Guerrero A, Matuskey D. Synapse. 2020 Mar; 2019 Sep 29. PMID: 31553807.
Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise.Matheson GJ, Plavén-Sigray P, Tuisku J, Rinne J, Matuskey D, Cervenka S. Eur J Nucl Med Mol Imaging. 2020 Feb; 2019 Nov 12. PMID: 31713656.
In vivo 5-HT(6) and 5-HT(2A) receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [(11)C]GSK215083 PET.Radhakrishnan R, Matuskey D, Nabulsi N, Gaiser E, Gallezot JD, Henry S, Planeta B, Lin SF, Ropchan J, Huang Y, Carson RE, D'Souza DC. Psychiatry Res Neuroimaging. 2020 Jan 30; 2019 Nov 12. PMID: 31760336.
Binge alcohol use is not associated with alterations in striatal dopamine receptor binding or dopamine release.Wai JM, Grassetti A, Slifstein M, Matuskey D, Nabulsi N, Ropchan J, Labaree D, Huang Y, Martinez D. Drug Alcohol Depend. 2019 Dec 1; 2019 Oct 17. PMID: 31669800.
Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.Zakiniaeiz Y, Hillmer AT, Matuskey D, Nabulsi N, Ropchan J, Mazure CM, Picciotto MR, Huang Y, McKee SA, Morris ED, Cosgrove KP. Neuropsychopharmacology. 2019 Dec; 2019 Jul 3. PMID: 31269510.
Reproducibility of the correlative triad among aging, dopamine receptor availability, and cognition.Juarez EJ, Castrellon JJ, Green MA, Crawford JL, Seaman KL, Smith CT, Dang LC, Matuskey D, Morris ED, Cowan RL, Zald DH, Samanez-Larkin GR. Psychol Aging. 2019 Nov; 2019 Oct 7. PMID: 31589058.
Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [(11)C]PBR28 HRRT PET study.Tuisku J, Plavén-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Brück A, Carson RE, Chen MK, Cosgrove KP, Ekblad L, Esterlis I, Farde L, Forsberg A, Halldin C, Helin S, Kosek E, Lekander M, Lindgren N, Marjamäki P, Rissanen E, Sucksdorff M, Varrone A, Collste K, Gallezot JD, Hillmer A, Huang Y, Höglund CO, Johansson J, Jucaite A, Lampa J, Nabulsi N, Pittman B, Sandiego CM, Stenkrona P, Rinne J, Matuskey D, Cervenka S. Eur J Nucl Med Mol Imaging. 2019 Oct; 2019 Jul 30. PMID: 31363804.
Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.Martinez D, Slifstein M, Matuskey D, Nabulsi N, Zheng MQ, Lin SF, Ropchan J, Urban N, Grassetti A, Chang D, Salling M, Foltin R, Carson RE, Huang Y. Neuropsychopharmacology. 2019 Sep; 2019 Apr 26. PMID: 31026862.
Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers.Matuskey D, Dias M, Naganawa M, Pittman B, Henry S, Li S, Gao H, Ropchan J, Nabulsi N, Carson RE, Huang Y. Neuropsychopharmacology. 2019 Sep; 2019 Mar 30. PMID: 30928993.
Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer (11)C-AS2471907 in Human Brain.Gallezot JD, Nabulsi N, Henry S, Pracitto R, Planeta B, Ropchan J, Lin SF, Labaree D, Kapinos M, Shirali A, Lara-Jaime T, Gao H, Matuskey D, Walzer M, Marek GJ, Bellaire S, Yuan N, Carson RE, Huang Y. J Nucl Med. 2019 Aug; 2019 Mar 15. PMID: 30877174.
In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation.Davis MT, Hillmer A, Holmes SE, Pietrzak RH, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Carson RE, Krystal JH, Esterlis I. Proc Natl Acad Sci U S A. 2019 Jun 4; 2019 May 13. PMID: 31085640.
A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers.Finnema SJ, Rossano S, Naganawa M, Henry S, Gao H, Pracitto R, Maguire RP, Mercier J, Kervyn S, Nicolas JM, Klitgaard H, DeBruyn S, Otoul C, Martin P, Muglia P, Matuskey D, Nabulsi NB, Huang Y, Kaminski RM, Hannestad J, Stockis A, Carson RE. Epilepsia. 2019 May; 2019 Mar 29. PMID: 30924924.
Partial-volume correction increases estimated dopamine D2-like receptor binding potential and reduces adult age differences.Smith CT, Crawford JL, Dang LC, Seaman KL, San Juan MD, Vijay A, Katz DT, Matuskey D, Cowan RL, Morris ED, Zald DH, Samanez-Larkin GR. J Cereb Blood Flow Metab. 2019 May; 2017 Nov 1. PMID: 29090626.
Lower synaptic density is associated with depression severity and network alterations.Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Pietrzak RH, Duman RS, Sanacora G, Krystal JH, Carson RE, Esterlis I. Nat Commun. 2019 Apr 4; 2019 Apr 4. PMID: 30948709.
Editorial.Matuskey D. Neurosci Lett. 2019 Jan 19; 2018 Oct 18. PMID: 30342079.
Positron emission tomography imaging of the γ-aminobutyric acid system.Andersson JD, Matuskey D, Finnema SJ. Neurosci Lett. 2019 Jan 19; 2018 Aug 10. PMID: 30102960.
PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.Cai Z, Li S, Matuskey D, Nabulsi N, Huang Y. Neurosci Lett. 2019 Jan 19; 2018 Jul 31. PMID: 30075287.
Kinetic evaluation and test-retest reproducibility of [(11)C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, Gallezot JD, Henry S, Hannestad J, Huang Y, Carson RE. J Cereb Blood Flow Metab. 2018 Nov; 2017 Aug 9. PMID: 28792356.
Age-Related Change in 5-HT(6) Receptor Availability in Healthy Male Volunteers Measured with (11)C-GSK215083 PET.Radhakrishnan R, Nabulsi N, Gaiser E, Gallezot JD, Henry S, Planeta B, Lin SF, Ropchan J, Williams W, Morris E, D'Souza DC, Huang Y, Carson RE, Matuskey D. J Nucl Med. 2018 Sep; 2018 Apr 6. PMID: 29626125.
The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [(11)C]FLB457 PET Study.Sandiego CM, Matuskey D, Lavery M, McGovern E, Huang Y, Nabulsi N, Ropchan J, Picciotto MR, Morris ED, McKee SA, Cosgrove KP. Neuropsychopharmacology. 2018 Apr; 2017 Sep 25. PMID: 28944773.
Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder.Scheinost D, Holmes SE, DellaGioia N, Schleifer C, Matuskey D, Abdallah CG, Hampson M, Krystal JH, Anticevic A, Esterlis I. Neuropsychopharmacology. 2018 Apr; 2017 Sep 25. PMID: 28944772.
Evaluation of (-)-[(18) F]Flubatine-specific binding: Implications for reference region approaches.Bhatt S, Hillmer AT, Nabulsi N, Matuskey D, Lim K, Lin SF, Esterlis I, Carson RE, Huang Y, Cosgrove KP. Synapse. 2018 Mar; 2017 Nov 17. PMID: 29105121.
Cerebellar and prefrontal cortical alterations in PTSD: structural and functional evidence.Holmes SE, Scheinost D, DellaGioia N, Davis MT, Matuskey D, Pietrzak RH, Hampson M, Krystal JH, Esterlis I. Chronic Stress (Thousand Oaks). 2018 Jan-Dec; 2018 Jul 6. PMID: 30035247.
Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures.Davis MT, DellaGioia N, Matuskey D, Harel B, Maruff P, Pietrzak RH, Esterlis I. J Affect Disord. 2017 Aug 15; 2017 Apr 27. PMID: 28460315.
Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.Holmes SE, Girgenti MJ, Davis MT, Pietrzak RH, DellaGioia N, Nabulsi N, Matuskey D, Southwick S, Duman RS, Carson RE, Krystal JH, Esterlis I. Proc Natl Acad Sci U S A. 2017 Aug 1; 2017 Jul 17. PMID: 28716937.
Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study.Abdallah CG, Hannestad J, Mason GF, Holmes SE, DellaGioia N, Sanacora G, Jiang L, Matuskey D, Satodiya R, Gasparini F, Lin X, Javitch J, Planeta B, Nabulsi N, Carson RE, Esterlis I. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jul; 2017 Apr 6. PMID: 28993818.
Regional and source-based patterns of [(11)C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D(2) and D(3) receptor availability in cocaine-use disorder.Worhunsky PD, Matuskey D, Gallezot JD, Gaiser EC, Nabulsi N, Angarita GA, Calhoun VD, Malison RT, Potenza MN, Carson RE. Neuroimage. 2017 Mar 1; 2017 Jan 19. PMID: 28110088.
Elevated Dopamine D(2/3) Receptor Availability in Obese Individuals: A PET Imaging Study with [(11)C](+)PHNO.Gaiser EC, Gallezot JD, Worhunsky PD, Jastreboff AM, Pittman B, Kantrovitz L, Angarita GA, Cosgrove KP, Potenza MN, Malison RT, Carson RE, Matuskey D. Neuropsychopharmacology. 2016 Dec; 2016 Jul 4. PMID: 27374277.
Imaging synaptic density in the living human brain.Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin SF, Chen MK, Dhaher R, Matuskey D, Baum E, Holden D, Spencer DD, Mercier J, Hannestad J, Huang Y, Carson RE. Sci Transl Med. 2016 Jul 20. PMID: 27440727.
Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.Matuskey D, Worhunksy P, Correa E, Pittman B, Gallezot JD, Nabulsi N, Ropchan J, Sreeram V, Gudepu R, Gaiser E, Cosgrove K, Ding YS, Potenza MN, Huang Y, Malison RT, Carson RE. Neuroimage. 2016 Apr 15; 2016 Feb 11. PMID: 26876475.
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, Matuskey D, Lee JY, O'Connor KC, Huang Y, Carson RE, Hannestad J, Cosgrove KP. Proc Natl Acad Sci U S A. 2015 Oct 6; 2015 Sep 18. PMID: 26385967.
A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.Matuskey D, Gaiser EC, Gallezot JD, Angarita GA, Pittman B, Nabulsi N, Ropchan J, MaCleod P, Cosgrove KP, Ding YS, Potenza MN, Carson RE, Malison RT. Drug Alcohol Depend. 2015 Sep 1; 2015 Jun 30. PMID: 26164205.
A case series on the heightened autonomic response due to guanfacine and amphetamine interaction.Gaiser EC, Matuskey D, Perkins E, D'Amico C, Abdelghany O, McKee SA, Cosgrove KP. J Clin Psychopharmacol. 2015 Apr. PMID: 25634160.
Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.Saricicek A, Chen J, Planeta B, Ruf B, Subramanyam K, Maloney K, Matuskey D, Labaree D, Deserno L, Neumeister A, Krystal JH, Gallezot JD, Huang Y, Carson RE, Bhagwagar Z. Eur J Nucl Med Mol Imaging. 2015 Mar; 2014 Nov 27. PMID: 25427881.
Memory reconsolidation for treatment-resistant aggression and self-injurious behaviors.Matuskey D, Sondik T. J Clin Psychopharmacol. 2015 Feb. PMID: 25502487.
Reductions in brain 5-HT1B receptor availability in primarily cocaine-dependent humans.Matuskey D, Bhagwagar Z, Planeta B, Pittman B, Gallezot JD, Chen J, Wanyiri J, Najafzadeh S, Ropchan J, Geha P, Huang Y, Potenza MN, Neumeister A, Carson RE, Malison RT. Biol Psychiatry. 2014 Nov 15; 2013 Nov 28. PMID: 24433854.
Gray matter volume correlates of global positive alcohol expectancy in non-dependent adult drinkers.Ide JS, Zhang S, Hu S, Matuskey D, Bednarski SR, Erdman E, Farr OM, Li CS. Addict Biol. 2014 Sep; 2013 Mar 6. PMID: 23461484.
The effects of methylphenidate on resting-state striatal, thalamic and global functional connectivity in healthy adults.Farr OM, Zhang S, Hu S, Matuskey D, Abdelghany O, Malison RT, Li CS. Int J Neuropsychopharmacol. 2014 Aug; 2014 May 13. PMID: 24825078.

Latest News

A Key Brain Difference Linked to Autism Is Found for the First Time in Living People

The power of collaboration

High-intensity Exercise May Reverse Neurodegeneration in Parkinson’s Disease

NeuroEXPLORER Images Unveiled at SNMMI

Yale Researchers Measure Ketamine's Effects on a Glutamate Receptor

Lower synaptic density is associated with depression severity and network alterations

Recent Publications